ChronoScale Corp (CHRN) awards director 200,000 restricted stock shares

Rhea-AI Filing Summary

Schaap Andrew Cordell reported acquisition or exercise transactions in this Form 4 filing.

ChronoScale Corp director Andrew Cordell Schaap received an equity grant of 200,000 shares of Common Stock as restricted stock. The grant was made on June 29, 2026 at a stated price of $0.00 per share and brings his reported direct holdings to 200,000 shares.

The award vests in two equal installments: 100,000 restricted shares vest on the one-year anniversary of the June 29, 2026 grant date and 100,000 restricted shares vest on the two-year anniversary. Vesting requires his continuous service with ChronoScale through each vesting date, with potential adjustment or accelerated vesting under certain conditions.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Schaap Andrew Cordell

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	200,000	$0.00	--

Holdings After Transaction: Common Stock — 200,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock grant: 200,000 shares Grant price per share: $0.00 per share Post-grant holdings: 200,000 shares +2 more

5 metrics

Restricted stock grant 200,000 shares Common Stock awarded June 29, 2026

Grant price per share $0.00 per share Restricted stock award to director

Post-grant holdings 200,000 shares Total Common Stock held directly after transaction

First vesting tranche 100,000 shares Vest on one-year anniversary of June 29, 2026 grant date

Second vesting tranche 100,000 shares Vest on two-year anniversary of June 29, 2026 grant date

Key Terms

restricted shares, Grant Date, continuous service, accelerated vesting, +1 more

5 terms

restricted shares financial

"Represents restricted shares of common stock of ChronoScale Corporation granted on June 29, 2026"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Grant Date financial

"granted on June 29, 2026 (the "Grant Date") which vest as follows"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

continuous service financial

"subject to the Reporting Person's continuous service with the Issuer through the applicable vesting date"

accelerated vesting financial

"subject to adjustment or accelerated vesting upon certain conditions"

Grant, award, or other acquisition financial

"transaction code description: Grant, award, or other acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/30/2026 - 05:17 PM Accepted by SEC EDGAR 06/30/2026 - 05:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schaap Andrew Cordell

(Last) (First) (Middle)

3811 TURTLE CREEK BOULEVARD

SUITE 2100

(Street)

DALLAS TEXAS 75219

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ChronoScale Corp [ CHRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/29/2026		A		200,000(1)	A	$0	200,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted shares of common stock of ChronoScale Corporation (the "Issuer") granted on June 29, 2026 (the "Grant Date") which vest as follows: (i) 100,000 restricted shares will vest on the one-year anniversary of the Grant Date; and (ii) 100,000 restricted shares will vest on the two-year anniversary of the Grant Date, subject to the Reporting Person's continuous service with the Issuer through the applicable vesting date and subject to adjustment or accelerated vesting upon certain conditions.

	/s/ Jerome Wong as Attorney-in-Fact	06/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ChronoScale Corp (CHRN) report for Andrew Schaap?

ChronoScale Corp reported that director Andrew Cordell Schaap received a grant of 200,000 restricted shares of Common Stock. The shares were awarded on June 29, 2026 at a stated price of $0.00 per share as part of his equity compensation.

How many ChronoScale (CHRN) shares does Andrew Schaap hold after this Form 4?

After the reported grant, Andrew Cordell Schaap is shown holding 200,000 shares of ChronoScale Common Stock directly. All of these shares relate to the restricted stock award reported in this filing and are subject to the specified vesting conditions.

What is the vesting schedule for Andrew Schaap’s 200,000 ChronoScale restricted shares?

The 200,000 restricted shares vest in two equal tranches: 100,000 vest on the one-year anniversary of the June 29, 2026 grant date and 100,000 vest on the two-year anniversary, conditioned on his continuous service with ChronoScale through each vesting date.

Is Andrew Schaap’s ChronoScale share grant tied to continued service?

Yes. The footnote states the restricted shares vest only if Andrew Cordell Schaap maintains continuous service with ChronoScale through each vesting date. The award may also be adjusted or receive accelerated vesting upon certain specified conditions in the grant terms.

Did Andrew Schaap buy ChronoScale (CHRN) shares on the market in this Form 4?

No. The Form 4 shows a transaction coded “A,” described as a grant, award, or other acquisition. It represents restricted stock granted by ChronoScale at $0.00 per share, rather than an open-market purchase of existing shares.